Transcription of Reflection paper on the dissolution specification for ...
{{id}} {{{paragraph}}}
Example: stock market
Reflection paper on the dissolution specification for ...
10 August 2017. EMA/CHMP/CVMP/QWP/336031/2017. Committee for Medicinal Products for Human use (CHMP). Committee for Medicinal Products for Veterinary use (CVMP). Quality Working Party (QWP). Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action Draft agreed by the QWP March 2016. Draft adopted by the CHMP for release for consultation March 2016. Draft adopted by the CVMP for release for consultation April 2016. Start of public consultation 13 May 2016. End of consultation (deadline for comments) 13 August 2016. Agreed by the QWP 24 May 2017.
1.1. Scope In the context of this reflection paper immediate release is identified as at least 75% (Q) of the active substance is dissolved within 45 minutes.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
FDA Guidance for Industry Dissolution Testing of, Immediate Release, Dissolution Testing, Release, Dissolution, Controlled-Release Capsule Formulation: Challenges and Solutions, Mg Prolonged-release Tablets PL, MG PROLONGED-RELEASE TABLETS, PL 27900, MG PROLONGED-RELEASE TABLETS PL 27900, Paper on the dissolution specification, Guideline for Bioequivalence, ASEAN GUIDELINE ON STABILITY STUDY OF, Oral drug delivery